American Journal of Ophthalmology
Volume 140, Issue 1 , Pages 23.e1-23.e7 , July 2005

Using Optical Coherence Tomography to Monitor Photodynamic Therapy in Age Related Macular Degeneration

,Accepted 25 January 2005.

References 

  1. Klein R , Klein BE , Linton KL . Prevalence of age-related maculopathy (the Beaver Dam Eye Study) . Ophthalmology . 1992;99:933–943
  2. Vingerling JR , Dielemans I , Hofman A , et al.   The prevalence of age-related maculopathy in the Rotterdam Study . Ophthalmology . 1995;102:205–210
  3. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group . Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of 2 randomized clinical trials—TAP report 1 . Arch Ophthalmol . 1999;117:1329–1345
  4. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group . Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two year results of 2 randomized clinical trials—TAP report 2 . Arch Ophthalmol . 2001;119:198–207
  5. Verteporfin in Photodynamic Therapy Study Group . Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration (two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2) . Am J Ophthalmol . 2001;131:541–560
  6. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) and Verteporfin in Photodynamic Therapy (VIP) Study Groups . Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin. Fluorescein angiographic guidelines for evaluation and treatment—TAP and VIP Report No. 2 . Arch Ophthalmol . 2003;121:1253–1268
  7. Huang D , Swanson EA , Lin CP , et al.   Optical coherence tomography . Science . 1991;254:1178–1181
  8. Sánchez-Tocino H , Álvarez-Vidal A , Maldonado MJ , et al.   Retinal thickness study with optical coherence tomography in patients with diabetes . Invest Ophthalmol Vis Sci . 2002;43(5):1588–1594
  9. Hee MR , Puliafito CA , Wong C , et al.   Quantitative assessment of macular edema with optical coherence tomography . Arch Ophthalmol . 1995;113:1019–1029
  10. Puliafito CA , Hee MR , Lin CP , et al.   Imaging of macular disease with optical coherence tomography . Ophthalmology . 1995;102:217–229
  11. Rogers AH , Martidis A , Greenberg PB , et al.   Optical coherence tomography findings following photodynamic therapy of choroidal neovascularization . Am J Ophthalmol . 2002;134(4):566–576
  12. Hee MR , Baumal CR , Puliafito CA , et al.   Optical coherence tomography of age-related macular degeneration and choroidal neovascularization . Ophthalmology . 1996;103:1260–1270
  13. Costa RA , Farah ME , Cardillo JA , et al.   Immediate indocyanine green angiography and optical coherence tomography evaluation after photodynamic therapy for subfoveal choroidal neovascularization . Retina . 2003;23:159–165
  14. Schmidt-Erfurth U , Michels S , Barbazetto I , et al.   Photodynamic effects on choroidal neovascularization and physiological choroid . Invest Ophthalmol Vis Sci . 2002;43(3):830–841
  15. Schnurrbusch UEK , Welt K , Horn LC , Wiedemann P , Wolf S . Histological findings of surgical excised choroidal neovascular membranes after photodynamic therapy . Br J Ophthalmol . 2001;85:1086–1091
  16. Moshfeghi DM , Kaiser PK , Grossniklaus HE , et al.   Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy . Am J Ophthalmol . 2003;135:343–350
  17. Blinder KJ , Bradley S , Bressler NM , et al.   Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration (TAP and VIP report no. 1) . Am J Ophthalmol . 2003;136:407–418
  18. Holz FG , Jorzik J , Schutt F , et al.   Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-Study) . Ophthalmology . 2003;110:400–405
  19. Kaiser RS , Berger JW , Williams GA , et al.   Variability in fluorescein angiography interpretation for photodynamic therapy in age-related macular degeneration . Retina . 2002;22:683–690
  20. Friedman SM , Margo CE . Choroidal neovascular membranes (reproducibility of angiographic interpretation) . Am J Ophthalmol . 2000;130:839–841
  21. Antcliff RJ , Stanford MR , Chauhan DS , et al.   Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis . Ophthalmology . 2000;107:593–599
  22. Schneeberg AE , Gobel W . Diagnosis and follow-up of non-diabetic macular edema with optical coherence tomography . Ophthalmologe . 2003;100:960–966
  23. Kang SW , Park CY , Ham DI . The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema . Am J Ophthalmol . 2004;137:313–322
  24. Yannuzzi LA , Rohrer KT , Tindel LJ , et al.   Fluorescein angiography complication survey . Ophthalmology . 1986;93:611–617

PII: S0002-9394(05)00113-3

doi: 10.1016/j.ajo.2005.01.044

American Journal of Ophthalmology
Volume 140, Issue 1 , Pages 23.e1-23.e7 , July 2005

Article Tools

* Image Usage & Resolution